Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

NCT03014297 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Part I completed. Part 2 will not be done due to sponsor decision.

Conditions

Neuroendocrine Tumors
Everolimus

Interventions

DRUG: everolimus
DRUG: fosbretabulin

Sponsor

Lowell Anthony, MD